Grow Your Expertise
Improve Patients’ Outcomes

World-class oncology and hematology Independent Medical Education designed to deliver data and insights that help you enhance your decision-making abilities and improve patients’ clinical results.

Start Learning Now!

My prIME:
Better Decisions Start Here

Get access to hundreds of live events and online activities that help advance your practice and improve clinical outcomes.
Watch My prIME Video

Explore the Best in Online Activities

 prIME Downloadable Slides 

November 20, 2018

Presentations From prIME Masterclass in NETs

Presentations From prIME Masterclass in NETs

 prIME Decision Points 

November 19, 2018

Decisions on PARP Inhibitors in Breast Cancer

Decisions on PARP Inhibitors in Breast Cancer

 Expert Review 

November 16, 2018

A Provocative Look at Multikinase Inhibitors

Expert Review

 Webcast 

November 15, 2018

New Options for HER2+ Breast Cancer Treatment

New Options for HER2+ Breast Cancer Treatment

 Webcast 

November 14, 2018

Assessing Immunotherapy in Bladder Cancer

Webcast

prIME LINES™

 :  November 20, 2018
Cisplatin Chemoradiation Remains Gold Standard for Low-Risk HPV+ SCCHN
Read more
First-Line Avelumab Plus Axitinib Outperforms Sunitinib in RCC
  November 15, 2018 Read more
Atezolizumab Combo, a New First-Line Option for Advanced NSCLC
  November 13, 2018 Read more
First-Line Pembrolizumab Superior to EXTREME in Metastatic SCCHN
  November 8, 2018 Read more